Hudson Bay Capital Management
TRPX

Hudson Bay Capital Management’s Therapix Biosciences Ltd. TRPX Stock Holding History

Hudson Bay Capital Management’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,055
Closed -$125K – 772
2019
Q1 		$125K Buy
+40,055
New +$163K ﹤0.01% 654

Other funds holding TRPX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Hudson Bay Capital Management's TRPX Position: Q2 2019 in Review

Hudson Bay Capital Management sold out of Therapix Biosciences Ltd. (TRPX) in Q2 2019, closing a stake of 40,055 shares — an estimated $125K sold.

Hudson Bay Capital Management first reported a position in TRPX in Q1 2019 and held it in 1 quarter. The position peaked at $125K in Q1 2019. 2 funds tracked by Wall St. Rank hold TRPX as of Q2 2019.

  • Hudson Bay Capital Management reported no remaining Therapix Biosciences Ltd. position as of Q2 2019 after selling out during the quarter.
  • Hudson Bay Capital Management sold 40,055 Therapix Biosciences Ltd. shares in Q2 2019, an estimated $125K.
  • Hudson Bay Capital Management first reported a position in Therapix Biosciences Ltd. in Q1 2019 and held it in 1 quarter.
  • Hudson Bay Capital Management's Therapix Biosciences Ltd. position peaked at $125K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q2 2019.

Based on Hudson Bay Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.